Cite
HARVARD Citation
de Wit, K. et al. (2020). Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ open gastroenterology. 7 (1), p. . [Online].